Daclizumab exhibits efficacy in multiple sclerosis subjects positive for interferon-beta neutralizing antibodies

被引：0

作者：

Neyer, Lauri ^{[1
]}

Singer, Robert ^{[1
]}

Wang, Helen ^{[1
]}

Caras, Ingrid ^{[1
]}

机构：

[1] PDL BioPharma, Preclin & Clin Dev Sci, Redwood City, CA USA

来源：

MULTIPLE SCLEROSIS | 2008年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S169 / S169

页数：1

共 50 条

[21] Interferon-beta neutralising antibodies in Canadian multiple sclerosis patients treated with different interferon-beta products
Grossberg, S. E.
Gehshan, A.
Long, C.
Chuppa, S. L.
Nicholson, K.
Grossberg, L. D.
MULTIPLE SCLEROSIS, 2006, 12 : S207 - S208
[22] NEUTRALIZING INTERFERON-BETA ANTIBODIES IN MELANOMA PATIENTS TREATED WITH RECOMBINANT AND NATURAL INTERFERON-BETA
FIERLBECK, G
SCHREINER, T
SCHABER, B
WALSER, A
RASSNER, G
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 39 (04) : 263 - 268
[23] Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosis
Florian Deisenhammer
Huub Schellekens
Antonio Bertolotto
Journal of Neurology, 2004, 251 : ii31 - ii39
[24] Commentary on neutralizing antibodies to interferon beta in patients with multiple sclerosis
Whitaker, JN
ARCHIVES OF NEUROLOGY, 2001, 58 (08) : 1301 - 1301
[25] Neutralizing antibodies to interferon beta: implications for the management of multiple sclerosis
Bertolotto, A
CURRENT OPINION IN NEUROLOGY, 2004, 17 (03) : 241 - 246
[26] Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosis
Deisenhammer, F
Schellekens, H
Bertolotto, A
JOURNAL OF NEUROLOGY, 2004, 251 (Suppl 2) : 31 - 39
[27] Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients
Enevold, Christian
Oturai, Annette B.
Sorensen, Per Soelberg
Ryder, Lars P.
Koch-Henriksen, Nils
Bendtzen, Klaus
MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (08) : 942 - 949
[28] Risk of cancer in multiple sclerosis patients who developed high concentrations of neutralizing antibodies against interferon-beta
Koch-Henriksen, N.
Magyari, M.
Johansen, C.
Sorensen, P. S.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 294 - 295
[29] Antibodies to interferon-beta in patients with multiple sclerosis: Detection and clinical effects
Sadiq, SA
Revesz, KJ
Lassman, AB
Miller, JR
NEUROLOGY, 1996, 46 (02) : 1073 - 1073
[30] INTERFERON-BETA FOR MULTIPLE-SCLEROSIS
CONNELLY, JF
ANNALS OF PHARMACOTHERAPY, 1994, 28 (05) : 610 - 616

← 1 2 3 4 5 →